Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentostatin, Cyclophosphamide, and Rituximab (PCR) in Previously Treated CLL
NCT00003658Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 1998
- Primary completion
- Oct 2005
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pentostatin, cyclophosphamide, rituximab in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenstrom macroglobulinemia (WM), follicular lymphoma (FL), sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 1998; status: completed.
02
Drugs
pentostatincyclophosphamiderituximab
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)Waldenstrom macroglobulinemia (WM)follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00003658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003658.